Skip to main content
Article
AngioVac Removal of an Isolated Infected Pulmonary Valve Papillary Fibroelastoma
Cardiology
  • Jessica Joseph-Alexis, HCA Healthcare
  • Aaron Jaffe, MD, HCA Healthcare
  • Jomel Jacinto, HCA Healthcare
  • Rami Akel, HCA Healthcare
Division
West Florida
Hospital
Regional Medical Center Bayonet Point
Document Type
Case Report
Publication Date
11-18-2020
Keywords
  • AngioVac,
  • endocarditis,
  • infective endocarditis,
  • papillary
Abstract

The AngioVac (Angiodynamics) system is indicated for the removal of right-sided venous soft thrombi and emboli. This is the first report that demonstrates the AngioVac system can be extended to the extraction of right-sided cardiac tumors, in the current case, a pulmonary valve papillary fibroelastoma infected with Streptococcus salivarius and Rothia species. (Level of Difficulty: Advanced.)

Publisher or Conference
JACC Case Reports
Citation Information
Joseph-Alexis J, Jaffe A, Jacinto JP, Akel R. AngioVac Removal of an Isolated Infected Pulmonary Valve Papillary Fibroelastoma. JACC Case Rep. 2020 Nov;2(14):2213-2216. https://doi.org/10.1016/j.jaccas.2020.10.008